Thank you for sharing such a detailed history. Based on the information provided, this child definitely warrants continued follow-up with a pediatric gastroenterologist, because the elevated fecal calprotectin together with growth concerns and iron deficiency suggests that there may still be an underlying inflammatory gastrointestinal process even though the upper endoscopy was normal.
1. Early Crohn disease / pediatric IBD: Yes, early Crohn disease is still possible. A normal upper endoscopy does NOT exclude Crohn disease because the disease can be limited to:
- terminal ileum - small bowel - colon
In children, growth delay, poor appetite, iron deficiency, and elevated fecal calprotectin can sometimes precede more classic symptoms like abdominal pain or diarrhea.
2. Low fecal elastase: Yes, intestinal inflammation itself can sometimes cause secondary/reversible low fecal elastase values, especially when stool consistency or mucosal inflammation affects the test. A borderline value (~129) is not diagnostic by itself for primary pancreatic insufficiency and often needs repeat confirmation.
3. Pancreatic involvement: At present, the pancreatic finding seems “possible but not definitive.” True pancreatic insufficiency usually presents with:
- greasy stools - chronic diarrhea - poor weight gain - fat-soluble vitamin deficiencies
Since these are not strongly present, the elastase result should be interpreted cautiously and possibly repeated.
4. Next investigations: Given the markedly elevated fecal calprotectin (521) plus growth concerns, colonoscopy with ileoscopy would be a very reasonable next step. MR enterography can also be very useful if small bowel Crohn disease is suspected.
5. Other possible explanations: Other inflammatory or immune-mediated conditions are possible, but pediatric IBD remains an important consideration. Less common causes may include:
- eosinophilic GI disease - immune dysregulation disorders - less common enteropathies
However, the current data does not strongly point toward a specific systemic genetic syndrome yet.
Overall impression: The elevated fecal calprotectin is probably the most clinically significant abnormality here and should not be ignored despite a normal upper scope. Further lower GI/small bowel evaluation is justified.
Final Prescription / Advice:
- Continue close pediatric GI follow-up - Ensure adequate nutrition, iron supplementation, hydration, and constipation management - Avoid empiric steroids or pancreatic enzyme therapy without specialist guidance
Recommended next step:
- Colonoscopy with terminal ileum evaluation - Consider MR enterography depending on pediatric GI assessment - Repeat fecal elastase if needed for confirmation
Advice: This case requires structured pediatric GI evaluation rather than symptomatic treatment alone.
Feel free to reach out again.
Regards, Dr. Nirav Jain MBBS, D.Fam.Medicine
Hello
A fecal calprotectin of 521 in a child is significant and usually deserves further evaluation, even when the upper endoscopy is normal. Crohn’s Disease can absolutely still be present because upper endoscopy only evaluates the upper GI tract, while Crohn disease in children often affects the terminal ileum and colon. So yes, colonoscopy with ileoscopy is a very reasonable next step, and many pediatric gastroenterologists would also consider MR enterography to assess the small bowel.
The borderline low stool elastase can sometimes be falsely low or secondarily reduced in the setting of intestinal inflammation, malnutrition, diarrhea, or diluted stool samples. A value around 129 is not diagnostic by itself for true Exocrine Pancreatic Insufficiency, especially without classic symptoms like greasy stools, chronic diarrhea, recurrent pancreatitis, or major weight loss. However, it should not be ignored and may need repeat testing or pancreatic-focused evaluation if symptoms progress.
The combination of poor appetite, mild growth delay, iron deficiency anemia, elevated calprotectin, and fatigue does keep inflammatory bowel disease fairly high on the list, even without diarrhea or abdominal pain. Children can present subtly. Other possibilities include less common immune/inflammatory disorders, eosinophilic GI disease, or nutritional/feeding-related problems contributing to growth issues, but the elevated calprotectin suggests true intestinal inflammation rather than simple picky eating alone.
A pediatric GI specialist would likely consider colonoscopy with biopsies, repeat fecal calprotectin, repeat elastase, ESR/CRP, nutritional markers, and possibly MR enterography. Monitoring height velocity, weight percentile, and pubertal development over time is also important because growth slowing can sometimes precede clearer GI symptoms in pediatric IBD.
Take care
Hi, thank you for sharing your son’s case. Very insightful workup so far.
Here are crisp, point-wise answers to your questions:
1. Early Crohn’s / IBD possible despite normal upper endoscopy? · Yes. Isolated small bowel or colonic Crohn’s can skip the upper tract. · Normal villi + negative celiac serology + HLA DQ2/DQ8 negative reliably rules out celiac. 2. Can intestinal inflammation cause low fecal elastase? · Yes. Highly elevated calprotectin (521) can dilute or degrade elastase, giving a falsely low level. · Repeat elastase when calprotectin normalizes is advised. 3. How concerning is pancreatic involvement? · Moderately concerning but not definitive. True pancreatic exocrine insufficiency is unlikely without diarrhea, fat malabsorption, or failure to thrive. · Low elastase here may be secondary, not primary pancreatic disease. 4. Next step: colonoscopy vs. MR enterography? · Both, in this order: · Colonoscopy with ileal intubation + biopsies – to look for Crohn’s, microscopic colitis, or other colonic inflammation. · MR enterography – to assess small bowel wall, rule out skip lesions, strictures, or perianal disease. 5. Systemic / immune explanation linking gut + pancreas? · Possible: autoimmune pancreatitis (IgG4-related), or Crohn’s with pancreatic involvement (rare but reported). · Also consider: immunodysregulation syndromes (e.g., IPEX, CTLA-4 haploinsufficiency) if early onset or family history. · Check IgG4, serum amylase/lipase, and pancreatic imaging (MRCP) if elastase remains low.
Final takeaway:
· Most likely: Mild IBD (Crohn’s) with secondary low elastase → colonoscopy + MR enterography. · Don’t ignore pancreatic axis – recheck elastase after inflammation controlled.
Dr. Nikhil Chauhan
Hello These are some thoughtful questions regarding potential early Crohn’s disease or pediatric inflammatory bowel disease (IBD). Let’s break them down:
1. Could this presentation be early Crohn’s disease / pediatric IBD even with a normal upper endoscopy? - Yes, it is possible. Crohn’s disease can affect any part of the gastrointestinal tract, and early stages may not always show abnormalities in the upper endoscopy. Symptoms and clinical history are crucial in making a diagnosis, and further evaluation may be necessary.
2. Can intestinal inflammation itself cause secondary low fecal elastase? - Yes, intestinal inflammation can lead to changes in pancreatic function, potentially resulting in low fecal elastase levels. This can occur due to inflammation affecting the pancreas or as a result of malabsorption.
3. How concerning is the pancreatic involvement in this context? - Pancreatic involvement can be concerning, especially if there are signs of pancreatitis or significant pancreatic dysfunction. It may indicate a more complex underlying condition that requires careful monitoring and management.
4. Would you recommend colonoscopy and/or MR enterography as the next step? - Yes, both colonoscopy and MR enterography can provide valuable information. A colonoscopy can help visualize the colon and obtain biopsies, while MR enterography is excellent for assessing small bowel involvement and inflammation. The choice may depend on the clinical scenario and the specific areas of concern.
5. Could there be another systemic or immune-related explanation connecting both intestinal inflammation and pancreatic findings? - Yes, conditions like autoimmune pancreatitis or systemic diseases (e.g., sarcoidosis, cystic fibrosis) can present with both intestinal inflammation and pancreatic involvement. A thorough evaluation of systemic symptoms and laboratory tests may help identify any underlying immune-related conditions.
It’s essential to work closely with a pediatric gastroenterologist who can provide tailored insights and recommendations based on the specific clinical context.
Thank you
This combination of elevated Fecal Calprotectin Elevation, iron deficiency, growth concerns, and poor appetite does make early Crohn Disease or another inflammatory intestinal disorder a reasonable concern even with a normal upper endoscopy, because Crohn disease in children can primarily affect the terminal ileum or colon and may be missed on upper GI evaluation alone. Intestinal inflammation can sometimes cause a secondary reduction in fecal elastase (especially with diarrhea or mucosal inflammation), so a borderline low elastase around 129 is not by itself definitive for true pancreatic insufficiency, but it does deserve follow-up and correlation with symptoms such as greasy stools, poor weight gain, fat-soluble vitamin deficiency, or recurrent abdominal pain.
Given the markedly elevated calprotectin and growth/iron issues, many pediatric gastroenterologists would strongly consider colonoscopy with ileoscopy and likely MR enterography next, because these are important for evaluating small bowel Crohn disease, subtle colitis, or less common inflammatory/immune conditions; repeating fecal calprotectin and elastase may also help determine persistence versus transient abnormalities. Other possibilities that can connect intestinal inflammation and pancreatic findings include immune dysregulation disorders, very early IBD-spectrum disease, eosinophilic or autoinflammatory conditions, and less commonly pancreatic disorders causing nutritional compromise, so continued follow-up with a pediatric gastroenterologist is important even though some tests so far are reassuring.
Given the symptoms and investigation results, it’s crucial to consider ongoing gastrointestinal inflammation or pancreatic issues when addressing your son’s condition. The elevated fecal calprotectin suggests significant intestinal inflammation, which could potentially indicate a form of inflammatory bowel disease (IBD) like Crohn’s, even if the upper endoscopy appeared normal. Crohn’s often affects the small intestine and colon, so a normal upper endoscopy doesn’t rule it out; the inflammation could be in parts initially untouched by endoscopy. Therefore, a colonoscopy, possibly with terminal ileal biopsies, should be the next logical step for more accurate assessment, evaluating parts of the GI tract not accessible during an upper endoscopic exam. An MR enterography could further delineate areas of inflammation or stricture unnoticed by other means.
As for fecal elastase, low levels can indicate pancreatic insufficiency, which might be secondary to chronic intestinal inflammation possibly impairing pancreatic enzyme output over time. While the pancreas’s involvement is notable, the borderline elastase value requires further context during ongoing assessment. Supply of pancreatic enzyme replacement could be trialed, especially as a bridging measure, depending on clinical judgment. Addressing iron deficiency anemia, by iron supplementation and nutritional guidance to ensure adequate caloric and protein intake, is necessary as well, especially in the context of growth delay and fatigue.
While systemic or immune-related conditions linking the bowel and pancreatic findings aren’t immediately clear given current genetic-testing results, they should remain on the differential list, explored through autoimmune panels or consultations with pediatric specialists in gastroenterology. Continued close follow-up with a pediatric GI is incredibly important as you navigate these diagnostic uncertainties, emphasizing early intervention to mitigate growth concerns and improve overall health outcomes.
